Trial Profile
A Phase I/II Study of Danusertib in Combination with Romidepsin in Adult Patients with Mature Peripheral T Cell Lymphoma (PTCL)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 22 Feb 2018
Price :
$35
*
At a glance
- Drugs Danusertib (Primary) ; Romidepsin (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma; Peripheral T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2018 New trial record